Romiplostim for Low Platelets in Sepsis
Part of Infections clinical trials.
This study tests a new drug called romiplostim N01 to help raise platelet counts in patients with sepsis (a serious blood infection). Low platelets during sepsis can increase bleeding risk, and this drug may help prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have sepsis (confirmed or suspected infection plus organ dysfunction)
- Your platelet count is very low (50 billion per liter or less)
- You have not received platelet-raising treatments in the past 2 weeks
- You have not used blood thinners or aspirin-like drugs in the past 3 weeks
- You are willing to follow the study protocol and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether platelet transfusions help patients with sepsis and very low platelet counts recover better. If you or your loved one had sepsis, a low platelet count, and were in the ICU for at least two days, this trial may be relevant.
This trial tests a drug called romiplostim for patients whose platelet counts stay very low (below 30) for a long time after chemotherapy, even after other treatments have failed. The goal is to see if romiplostim can help raise your platelet count to a safer level.
This trial tests a drug called Romiplostim to help raise low platelet counts caused by leukemia treatment. It is for adults with leukemia whose platelets are below 50 and who may benefit from this therapy.
This trial tests if romiplostim, a drug that helps the body make platelets, can speed up platelet recovery after a special type of stem cell transplant from a half-matched donor. It may help reduce bleeding risk during the recovery period.
This trial tests a medicine called romiplostim (Nplate) as a first treatment for adults newly diagnosed with ITP. It aims to see if it can safely raise platelet counts and reduce bleeding risk.
This trial tests a drug called romiplostim to help raise platelet levels in children and young adults (ages 6–24) whose platelets drop due to chemotherapy. It’s for those with solid tumors or other non-marrow cancers who are still getting strong treatment.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.